Roth Capital Markets analyst Jason Wittes raised his price target on Zimmer Biomet Holdings ( Zimmer Biomet Holdings Stock Quote, Chart, News, Analysts, Financials NYSE:ZBH) to $135 and maintained a ...

Zimmer Biomet ( NYSE: ZBH) was upgraded at Roth Capital Partners to Buy from Neutral on the back of its recent acquisition of Monogram Technologies, a company specializing in robotics.